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Previous studies of passive cutaneous anaphylaxis (PCA)  x in the albino rat 
led to the concept that this allergic tissue response was mediated in part by a 
host  factor  resembling  complement  (C  I)  (1).  Subsequently,  the  thesis  was 
advanced  that  allergic  reactions  of  the  immediate  type  occurred  at  a  cell 
surface  where  molecules  of  attached  antibody  reacted  with  antigen  in  the 
presence of an excess of C 1 provided by the circulating blood. This interpreta- 
tion of the experimental data was not considered to be unique in view of the 
technical complexities and theoretical limitations associated with experiments 
in the intact animal (2, 3).  These considerations have led to a  more detailed 
study of an in vitro model as an additional effort to define more precisely the 
role  of  C' in  anaphylactic reactions.  This model is  derived from the  studies 
of Friedberger, Bordet, Novy, and de Kruff (see reference 2 for review of earlier 
literature)  and is based on the utilization of a  cell-free reaction system com- 
prising  antigen,  antibody,  and  fresh  serum.  The  importance  of  this  model 
pertains to the observation that the loss of hemolytic potency following antigen- 
antibody interaction  in  fresh  serum is  also  associated  with  the  genesis  of  a 
substance(s)  called  anaphylatoxin  which  is  endowed  with  the  capacity  to 
* Presented in part at the annual meeting of the American Academy of Allergy, Chicago, 
1959, and before the American  Association  of Immunologists,  Atlantic City, 1959. This investi- 
gation was carried out under the auspices of the Commission on Cutaneous Diseases of the 
Armed Forces Epidemiological  Board, and was supported in part by the Office  of The Surgeon 
General, Department of the Army, and in part by the National Science Foundation and the 
American  Heart Association. Part of the studies were also carried out under terms of a contract 
between Fort Derrick, Frederick, Maryland, and the School of Medicine, The Johns Hopkins 
University. 
1 PCA, passive cutaneous anaphylaxis. 
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contract smooth muscle and augment capillary or minute vessel permeability. 
Although the use of this model system may be regarded as an oversimplified 
and perhaps  tangential  approach  to  the  study of  anaphylactic  phenomena, 
its  present application has resulted in several pertinent findings  with respect 
to the mechanism of these reactions.  The  use of a  cell-free  reaction medium 
also effects a physical separation of those processes  which lead to the forma- 
tion of a substance injurious to tissues from those concerned with the tissue re- 
sponses  engendered by it.  The study of each of these reaction sequences  is 
thereby facilitated.  Further,  the product of  these  C'  fixation  reactions  may 
be characterized in terms of those tissue responses  intimately  associated with 
allergic  reactions  of the  immediate  type,  the  capacity  to  contract  smooth 
muscle and to  enhance  capillary  permeability  (4-7).  The  experiments  de- 
scribed in this report may be considered to offer the type of evidence required 
to establish a  sequential and causal  relationship  between the  fixation  of  C' 
and  those  processes  ascribed  to  the  tissue  injury  characteristic  of  allergic 
reactions of the immediate type. 
Malzrials and Methods 
The basic experimental design for these studies can be briefly outlined as follows. Antigen 
and antibody were added as preformed immune aggregates (PIA) 2 to fresh rat or guinea pig 
serum under  the experimental conditions designated below. At appropriate  time intervals, 
aliquots of these reaction mixtures were centrifuged at approximately 12,000 g for 30 minutes 
at 0°C. and the supemates assayed for: (a) hemolytic potency, i.e., C' fixation; (b) C' activity; 
(¢) capillary permeability enhancement in the guinea pig skin; and (d) ability to contract nor- 
real guinea pig ileum in a Schultz-Dale bath. 
In most of the experiments, the C' fixation estimates were performed prior to centrifugation 
since it had been demonstrated that dilution of the reaction mixture in ice-cold buffer sufficed 
to arrest further C' utilization even in the initial stages of the fixation process (8). In some of 
the experiments all four assays were carried out on the same day. When this was not practica- 
ble, aliquots were removed for the C' fixation estimates, and the remainder of the supemates 
was centrifuged, diluted with an equal volume of 0.02  ~  NasHEDTA  8 in isotonic sodium 
chloride, and stored in tightly stoppered glass vials at -50°C. 
Preformed Immune Aggregates (PIA).--Many preliminary experiments were performed in 
which rabbit antisera were reacted with the appropriate antigens in fresh rat or guinea pig 
serum. For the experiments described in this report, the immune reactants were in the form 
of PIA except as noted in Table I. These preparations were preferred since they contained a 
minimum of extraneous serum and non-antigenic constituents. The following account describes 
a representative preparation. Rabbit anti-ovalbumln serum was obtained following immuniza- 
tion with a commercial, twice-crystallized ovalbumin (Ea) preparation  4 in Freund adjuvants. 
The sera of three rabbits, bled at repeated intervals, were pooled and heated at 56°C.  for 30 
minutes. This serum pool, labelled 134-5, was then clarified by centrifugation at 0°C. for 60 
minutes at 12,000 g, and analyzed by the quantitative precipitin technique (9). To 25 nil. of 
2 PIA, preformed immune aggregates. 
a NA3HEDTA, tridsodium ethylenediamine tetraacetate. 
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this antiserum containing 0.722 precipitable antibody N per ml., were added 4.9 ml. of a centri- 
fuged Ea solution (0.352 rag.  N  per ml.) to attain an antibody: antigen ratio approximating 
10.5. The equivalence zone ratio for these reagents was slightly lower; i.e., 9.5. The antiserum 
and Ea solution were thoroughly mixed and incubated at 37"C.  for 3 hours, centrifuged at 
12,000 g and washed until the supemates were free of protein as judged by optical density 
measurements in a  DU model Beckman spectrophotometer at 278 m#. For this preparation 
three washings, each with 30 ml. of cold saline, sufficed.  The washed precipitate was resns- 
pended in 36 ml. of saline containing 0.1 per cent merthiolate and stored at 0°C. Antibody N 
estimates for the PIA were determined for total BT analyses by the micro-Kjeldahl method 
(9) or from optical density measurements in 0.25 M acetic acid as described in (10) with the 
aid of appropriate conversion factors for the Ea solution and for rabbit antibody as given in 
reference 11, and as confirmed in this laboratory.  For the preparation described above, the 
anti-Ea N  content in the resnspended PIA was 0.450 mg. per ml. Appropriate dilutions were 
prepared as required. 
Complonent.--Pooled guinea pig and rat sera were used as the source of C'. The former was 
obtained commercially in the frozen state from the Hyland Laboratories, Los Angeles,  and 
generally contained about 220 C'I-Is0 per nil. when titrated as described in reference 12 after 
absorption with packed sheep erythrocytes. Rat serum was obtained by exsanguinating albino 
rats  of the Wistar strain,  or commercially from the Hyland  Laboratories.  The pooled rat 
serum generally contained between 40 and 45 C'H~ per ml. after absorption in the cold with 
washed, packed sheep erythrocytes. Further details regarding the preparation,  storage, and 
estimation of C' activity for lyric and C' fixation potendes have been given in the previous 
report (1) as modified from that reported in reference 13 for application to rat serum. 
C~ Estimations.--These titrations were carried out by the method of Rapp (14) as modified 
in reference 15. The method is based on the observation of Costa Cruz and Azevedo Penna 
(16, 17) relative to the specific inactivation of C~ by formaldehyde. For the purposes of this 
investigation, guinea pig serum was treated with formalin as outlined in reference 15, and then 
reacted with sensitized sheep erythrocytes to yield the intermediate EAC~,4,~ as described by 
Mayer (18). These cells served as an appropriate substrate for estimations of C~ activity in 
terms of C'3H50, the dilution of serum which will hemolyze 50 per cent of the EAC~,4,t ceils 
in the test carried out in the presence of 0.01  M EDTA (trisodium ethylenediamine tetra- 
acetate, NaffIEDTA). The number of C'3H50 in untreated and pooled rat serum has been 
found to vary between 120 and 180 in most of the experiments. This variation is due almost 
entirely to changes in susceptibility of the treated erythrocytes as prepared on dilterent days. 
In view of this uncontrolled variation, the degree of C~ inactivation attributable to a specific 
treatment has been estimated in terms of the potency of untreated rat serum included in each 
of the titration series. 
Estimations of Capillary Permeability Changes.--These assays  were carried  out in male 
albino guinea pigs weighing 230  to 270 gin.  (19).  The fur on the backs of the animals was 
shaved the day before testing. In the test procedure, each animal received an intravenous in- 
jection of 1 ml. of 0.5 per cent Evans blue in saline and immediately thereafter, 6 intradermal 
injections of 0.1 ml. aliquots of the various test materials. The animal was sacrificed 60 min- 
utes after the intradermal injections and the reactions measured with a transparent millimeter 
ruler placed over the blue spot on the inner surface of the skin. On the basis of many pre- 
liminary dose-response studies,  it was concluded that  valid comparisons between different 
treatments might best be made when the reaction mixtures were diluted in isotonic NaCl to 
yield a  1 ~  75 final dilution of the rat serum used as a  C' source.  The value given for the 
diameter of the skin response obtained with each test substance in the tables below, represents 
an arithmetic mean of six replicates. Each replicate was randomized as to site and guinea pig 
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Glenn E. Bartsch of the Biostatistics Department of the Johns Hopkins School of Hygiene and 
Public Health (20). The injection materials were coded and the reactions measured by two 
individuals. An "adjusted treatment mean" was calculated for each of the sixteen substances 
or treatments in every experiment. The sixteen values thus obtained could be compared by a 
single standard error of the difference irrespective of the differences in reactivity between 
guinea pigs and sites of inoculation. The precision inherent in data of this type may be indi- 
cated by the observation that the standard error of the difference between mean reaction 
diameters of different test substances ranged from 0.8 to  1.8 mm. in individual sets of the 
many assays conducted during the course of this investigation. 
It should be noted that these skin reactions are not comparable to PCA reactions such as 
reported in reference 1. In the present situation a dilution of the reaction mixture is placed in 
the skin and results in a  very rapid liberation of histamine or other permeability factors, 
without further intervention of antigen, antibody, or appreciable latent period. The areas of 
skin blueing become visible within a  few minutes after injection. Despite the statistical and 
other methodological precautions, the total range of quantitation is limited to reactions with 
a minimum diameter of about 6 ram. (produced by saline or untreated serum) to a maximum 
rarely exceeding 18 to 20 mm. This relative compression of the range of observations sharply 
limited the ease in detecting some of the more subtle differences that were encountered in the 
other assay procedures. 
The use of guinea pig serum for the study of capillary permeability changes induced by 
antigen-antibody interaction is attended by yet  greater complexities than those discussed 
above for the rat serum. Reference is made to the possible interplay of multiple permeability 
factors and inhibitors, as described by Miles and Wilhelm (21,  22).  On the basis of many 
experiments, it appeared that a valid assay procedure for permeability factors in experiments 
with guinea pig serum was potentially available when the precautions described in (21,  22) 
were followed. However, the lack of definitive knowledge as to the possible relationship be- 
tween anaphylatoxin and the other permeability factors in guinea pig serum  discouraged 
extensive efforts along these lines for the present. 
Estimations of Sraooth Muscle Con~raaion.--These assays have been carried out in a modi- 
fied Schultz-Dale apparatus developed on the basis of an original design by Dr. Samuel A. 
Talbot and his associates in the Biophysics Division of the Department of Medicine at this 
institution. Details as to construction, operation, and validation of the assay technique are 
currently being assembled for publication (23). For present purposes it may be indicated that 
the contraction of segments of guinea pig ileum bathed in oxygenated Krebs buffer is measured 
under isometric conditions (24) with an RCA 5734 triode (25) transducer. Under these condi- 
tions, 0.4 #g. of histamine dihydrochloride in isotonic NaC1,  when added in a  volume of 0.2 
ml. to the 20 ml. tissue bath, results in a tension increase sufficient to yield a reading of 60 to 
70 ram. or more on a G-10 varian recorder. Untreated mt serum in a volume of 0.2 ml. generally 
yields a contraction equivalent to less than 5 mm., about 10 per cent or less than that for an 
active axmphylatoxin preparation. In this respect, the range of effective quantitation is mark- 
edly increased over that for the guinea pig skin-blueing assay. Moreover, the Schultz-Dale 
procedure is not hampered by the appreciable blank values (ca. 30 per cent) elicited with 
normal rat serum in the dye technique for estimation of capillary permeability. 
The values listed in the tables below under the columns headed "Schultz-Dale response" 
represent an arithmetic mean of tests with five replicate aliquots. Each aliquot was tested in 
a volume of 0.2 ml. which represents a  1 --* 2 dilution with an equal volume of 0.02 m EDTA 
on each of five successive segments of guinea pig ileum. The assays were performed in a Latin 
square design involving five preparations and five segments of ileum. This design was also of 
value in minimizing the effects of tachyphylmds as emphasized recently by Rocha e Silva and 
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EXPERr~F,  NTAL RESULTS 
The data in Table I serve  as a basis  for  comparing the efficacy  of  preformed 
immune aggregates (PIA) in C t  fixation,  C~3 inactivation,  and anaphylatoxin 
production,  ~ with similar  concentrations of antigen and antibody reacting in 
the presence of fresh  rat serum. This comparison was undertaken because of 
earlier  findings  which related the aggregating properties of antibody to C t 
fixing  potency (discussed  in reference  2?).  The diminished Ct-fa~ng activities 
of  preformed aggregates  noted  previously  in  more highly  dilute  reaction  systems 
with guinea pig C r (8,  27) do not seem applicable in the present studies with 
more concentrated reagents, such as undiluted C r and much higher concentra- 
tions of antibody (c/.  tubes  1 to 5 and 8 to 11).  Of more immediate interest 
are  the  findings in  Table  I  which  demonstrate  that  approximately similar 
levels of C'~ are destroyed by the addition of antigen and immune serum as 
separate reagents or in the combined state as PIA. In addition, the progressive 
destruction of C  ~ is accompanied by increased anaphylatoxin activity in the 
supernates. Finally, heat-inactivated rat serum does not serve as a  vehicle for 
producing  increased  capillary permeability by  PIA  (c/.  also  reference  28). 
This finding also negates the possibility that trace levels of immune complexes, 
possibly dissolved by the serum and not removed  by the centrifugation pro- 
cedure, are responsible for the biological effects observed with the supernates. 
This interpretation assumes that  the solubilizing property of fresh serum for 
PIP, is no greater than that of heated serum, an  inference in line with the 
findings in references 29 and 30, and one that is borne out in  subsequent ex- 
periments. An additional point of some interest with regard to the tissue fixation 
of antibody in systemic anaphylaxis is  the observation that immune serum, 
in the absence of antigen (tube 13) showed some destruction of C~3 as well as a 
slightly enhanced, and possibly significant, capillary permeability effect. This 
property is attributable to gamma globulin as shown in experiments conducted 
in this laboratory, as well as those of Bier (31)  and Ishizaka and Campbell 
(32)6. 
The parallelism provided by the data in Table I  with respect to the fixation 
of C  r and anaphylatoxin formation was extended in an experiment designed 
to compare the efficacy of PIA prepared at equivalence zone and antigen excess 
ratios. These aggregates were prepared from rabbit anti-pneumococcus Type 
III serum and the corresponding capsular polysaccharide, SIII. A time course 
study was undertaken to provide a  more detailed basis for comparison with 
5 The assumption  is made  that  anaphylatoxin  represents a  single compound  capable of 
inducing smooth muscle contraction and enhanced capillary permeability. The validity of the 
assumption that only a single substance is involved in both activities is currently under inves- 
tigation. 
6 We wish to thank the authors for the privilege of reading this manuscript in advance  of 
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previous studies in a more highly dilute system (8). The results of this experi- 
ment as summarized in Table II and Figs.  1 to 4 confirm the many earlier 
observations in showing an inhibition of C' fixation by excess antigen. As was 
shown with the protein immune system (Table I, cf.  also Table V), the poly- 
TABLE  I 
Fixation of Complement and Formation of Anapkylatoxin  by the Addition  of Preformed Immune 
Aggregates to Rat Serum and by the Interaction of Antigen wlth Antibody in the Presence 
of Rat Serum 
Rat serum* 
Incubated for 37°C.-90 
rain. with I rot.  C'Hil fixed, C'SH~ lost  Tube  Heated  containing 
Unheated  S6°C-30 
mh~. 
ml.  ml,  ~.  ram.  mm.~ 
1  5.0  --  20 PIA§  85  274  13.611  22 
2  5.0  --  40 PIA  112  290  15.2  20 
3  5.0  --  80 PIA  145  465  15.7  62 
4  5.0  --  160 PIA  152  530  16.9  63 
5  5.0  --  320 PIA  >  162  550  16.7  54 
Diameter  Schultz. 
of  skin  Dale 
response  response 
6  --  5.0  80 PIA  6.9 
?  --  5.0  320 PIA  8.0 
8  5.0  --  20 a-Ea¶  98  207  13.6 
9  5.0  --  40 a-Ea  118  265  15.1 
10  5.0  --  80 a-Ea  157  326  15.7 
11  5.0  --  320 a-Ea  164  550  17.2 
12  5.0  --  80 a-Ea control  5  45  9.0 
13  5.0  --  320 a-Ea control  20  321  10.1 
14  5.0  --  Buffer  None**  None~:~  8.4 
15  --  5.0  Buffer  9.1 
* Pool of serum from adult Wistar rats absorbed twice with washed sheep erythrocytes. 
Each absorption carried out at 0°C. for 60 minutes with 1.0 ml. of packed red cells per 30 
ml. of serum. 
Each number refers to the arithmetic mean of five replicate assays carried out on five 
successive pieces of ileum from one guinea pig. The term "Schultz-Dale response" is used to 
identify the type of tissue bath used for the estimations of smooth muscle contraction. The 
response of these preparations in the present study is not a  Schultz-Dale response in the sense 
which involves the addition of antigen to a  segment of sensitized tissue. 
§ Micrograms of rabbit  anti-Ea N  in the washed specific precipitate containing Ea at an 
antibody N:antigen  N  ratio  of  10.5:1. 
II Standard  error  of  the  difference  for  these  values ffi 0.94  mm. 
¶  Micrograms of rabbit  anti-Ea N  reacted  with  an equivalent amount of Ea  N  at  an 
antibody: antigen N  ratio of 10.5: I. In these tubes, the precipitate was formed in the presence 
of rat serum. 
** This tube contained 172 C'H~0 after incubation at 37°C. for 90 minutes. 
$~ This tube contained 712 C~3I~0. A.  G.  OSLER, H.  G.  RANDALL, B.  M.  HILL, AND  Z.  OVARY  317 
saccharide reactants at equivalence zone ratios also exhibit a  progressive in- 
crease, with time, in the fixation of C r, inactivation  of C~3 capillary permeability 
enhancement, and ability to contract guinea pig ileum. In striking contrast, the 
intensity of  each of  these four activities is markedly reduced when the con- 
figuration of the immune aggregates is altered through the addition of excess 
antigen (flask B). The loss of hemolytic potency through fixation is diminished 
TABLE II 
Fixation  of Complement and Formation of Anapkylatoxin:  Comparative E~cacy  of Wasked 
PIA  at Ratios  Corresponding to F~ui~alence and Marked Antigen  Excess 
10.19 
31.21 
65.08 
Flask 
1.61 
4.71 
10.35 
31.51¶ 
60.0¶ 
60.0** 
T  Diameter  of  ~  Schultz-Dale  T  C'Hs0 fixed*  T  C'3H6o lost$  skin response  "  response 
Flask A--preformed SIII-rabbit-anti-SIII  aggregates at equivalence zone ratio 
1.90  244  2.98  2.54  10.3  2.98  7  ° 
4.92  372  6.07  355  5.58  6.07  8 ° 
567  11.42  600  10.84  13.3  11.42  13 ° 
1183  32.62  940  32.00  16.3  32.62  30 °  444 
1212  66.26  1265  65.62  16.4  66.26  36 c 
B--preformed  SIILrabbit-anti-SIII aggregates  in  SIII  excess 
161  2.87  38  2.26  9.7  2.87  5  b 
330  6.21  149  5.49  9.1  6.21  4  b 
366  11.57  113  10.96  11.4  11.57  11 ~ 
373  32.73  149  61.01  12.4  61.49  144 
--  60.00  10.3  60.00 
0  0  10.3 
Each flask contained 27.5 ml. of rat serum plus 5.5 ml. of SIII-rabbit-anti-SIII  N aggre- 
gates (20/zg. N per ml.) at ratios of antibody N:SIII approximating equivalence zone (R = 
8.3) and SIII excess (R --- 0.1). 
* The initial number of CJH~0 available for these reactions was 1320. 
:~ The initial number of Ct3I-Is0 units available for these reactions was 4400. 
§ Standard error of the difference =  1.5. 
** Fresh rat serum control without PIA. 
[] Each superscript identifies the specimens which were assayed with segments of ileum 
from the same guinea pig. 
¶ 2.5 ml. of heated rat serum (56°C.-30 rain.) plus 0.5 ml. of PIA at SIII excess ratios. 
from a  maximum of about 1200 to 400 C'H60 despite the presence of identical 
amounts of antibody in the two flasks. This diminution  is also associated with 
less  Cr3 inactivation, an event likewise reflected in the guinea pig skin tests 
and smooth muscle assays. 
The disparate potencies of PIA at equivalence zone and antigen excess ratios 
with  respect  to  C'  fixation and anaphylatoxin formation provide seemingly 
substantial evidence as to a  possible causal interrelationship between the two 
processes. In an attempt to subject this tentative conclusion to more critical 
experimental scrutiny, conditions were  sought for  the  possible separation of r~ 
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these processes as outlined in a series of experiments summarized by the data 
in Table III. A study of these results indicates that under certain experimental 
conditions, the fixation of C' as estimated in terms of a loss in hemolytic ac- 
tivity may occur without initiating  anaphylatoxin production,  provided the 
loss in C'3 potency is only minimal. 
Further,  the loss  of  C'  component activities  through  non-immune  mech- 
anisms does not seem to mediate significant  anaphylatoxin activity, as shown 
by the data for tubes I, 2, 3, 9, 14, 16, and 18, in Table HI. It had been noted 
previously by Mrs.  Eugene  Rodriguez of  this  laboratory,  and  is  presently 
confirmed, that the hemolytic potency of rat serum is relatively labile to storage 
in the cold, as compared to guinea pig C'. More than 50 per cent of the lyric 
activity disappeared under these conditions (tube 9) without inducing increased 
skin blueing or smooth muscle contraction. Neither did treatment of the C' 
with hydrazine  (tube  16),  heparin  (tube  14),  or formalin  (tube  18)  for the 
preferential inactivation of C'~ or C'8 lead to anaphylatoxic activity. The loss 
of hemolytic activity through specific immune fixation  at low temperatures is 
not an  adequate precondition for generating  the biological  properties under 
study. Under these conditions,  loss in activity may be attributed almost en- 
tirely to the interaction of C'1, C',, and  C'2 with PIA. For example,  in tube 
10, 169 out of 196, or 86 per cent of the C'H60 were fixed. In this tube only 152 
of 730 units, or 21 per cent of the activity attributed to C'8 was lost, a slight 
augmentation  in  capillary  permeability  properties  was  noted  but  this  was 
unaccompanied by any increase  in the smooth muscle tests. In contrast,  the 
same loss in lyric C' activity was observed in tube 13, in which fixation was 
carried out at 37°C. Under these conditions more than 80 per cent of the C'8 
activity was destroyed with abundant anaphylatoxin production. 
The pertinence of C'3 utilization in the mediation of anaphylatoxin produc- 
tion  by immune  mechanisms,  gains  increasing  interest  in  the  light  of  the 
many  observations  showing  that  the  interaction  of  this  component  occurs 
only after C'1, C'~, and  C', have participated  in the reaction sequence (18). 
In line  with this reasoning,  it was also noted that  the destruction of C', by 
hydrazine, or the destruction of C'3 by formaldehyde (tube 19) suffice to arrest 
or inhibit the full utilization of C' and the consequent formation of anaphyla- 
toxin (of. also references 33 and 34). 
The results obtained with the reaction mixtures in tubes 10 and 12 are also 
of interest  with  respect to  the mechanism  of anaphylatoxin  production.  In 
tube 10, incubation of rat serum with PIA at 0°C. yielded almost complete C' 
fixation  (169  out of  196  C'H60) in terms  of loss  in hemolytic potency with 
little  or  no  C'a  destruction  or  anaphylatoxin  production.  When  PIA were 
added a second time as in tube 12, presumably much of Ctl, C',, or Ct~ had been 
rendered unavailable, yet that fraction which remained apparently sufficed to 
initiate marked C'3 destruction, enhanced capillary permeability and Schultz- A. O. 0SLER~ H. G. RANDALL~ B. M. HILL~ AND  Z. OVARY  321 
TABLE  III 
Fixogion of Cotnplemenl and Formation of Anaphylaloxin: E~ect of Temperature and A~ailabigity 
of C' Compon~ts 
Tube 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Treatment of rat serum 
~Tone 
Incubated 60 rain. at 0°C. 
Incubated60min. at 37°C. 
Plus PIA, 60 rain. at 0°C. 
Plus PIA, 60 rain. at 15°C. 
Plus PIA, 60 rain. at 37°C. 
Plus  PIA,  60  rain.  at  0°C.; 
centrifuged  and  incubated 
60 rain., 37°C. 
Same as tube 7 but PIA added 
again  and  incubated  60 
rain., 37°C. 
Incubated 18 hrs. at 0°C. 
Plus PIA, incubated 18  hrs., 
0°C. 
Incubated 60 min., 37°C. 
Same as tube 10, then centri- 
fuged;  PIA  added  again 
and  incubated  60  rain.  at 
37°C. 
Plus PIA, 60 rain., 37°C. 
Heparin  (100 mg.),  60  rain., 
37°C. 
Same as tube 14 plus PIA 
Hydrazine, 0.036 M, 60 rain., 
37°C. 
Same as tube 16 plus PIA 
HCHO (0.1 per cent), 40 
rain., 37°C. 
Same as tube 18 plus PIA 
C'H~ fixed* 
170 
0 
73 
>190 
>190 
>190 
>190 
C'3H. festa: Diameter of  Schultz-Dale 
skin response  response 
ram.§ 
0  0  6.4 
13  10  6.7 
44  39  7.1 
36  38  6.8 
113  139  10.3 
187  371  13.0 
98  96  6.5 
186  409  12.6 
100  78  8.0 
169  152  11.2 
0  0 
192  510  15.9 
>600  17.0 
295  6.6 
450  12.9 
262  8.9 
262  8.3 
>700  7.1 
>7OO  5.8 
4 a 
5" 
5 & 
27, 
31 a  45  b 
o b 
13  b 
5  b 
6 b 
0 
0 
The PIA consisted of rabbit-anti-Ea +  Ea at a level of 20 #g. of anti-Ea N per ml. of reac- 
tion mixture. 
Tubes 1 through 8, and 9 through 19 represent experiments conducted at different times. 
All tubes contained 5.0 ml. of rat serum in a  total reaction volume of 6.0 nil. 
* 196 C'H~ available. 
494 C'3H50 available in tubes 1 through 8; 730 in tubes 9  through 19. 
§ Standard error of the difference =  0.94 for tubes 1 through 8, and 1.3 for tubes9 through 
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Dale  response  upon renewed  addition of  the inciting immune reactants,  A 
somewhat similar  comparison  emerges from the data in tubes 7 and 8. One 
interpretation of these data implies that the interaction of all the identified C  t 
components  must  precede  anaphylatoxin formation.  This  formulation en- 
compasses the findings of Rapp (35) and of Amiraian (36) relative to the pos- 
TABLE IV 
Fixation of Complement and Formation of Anaphylatoxin: Inhibition  by EDTA  (Trisodiura 
Ethylene Diaminetetraacetat~  and Restoration by Divalent Cations 
Flask  Treatment 
A  Rat serum plus 
preformed im- 
mune aggre- 
gates 
B  Same  as "A" 
but contain- 
ing 0.01 M 
EDTA 
Then followed 
by addition 
of Mg  ++ and 
Ca++ 
T 
1.91 
7.94 
28.29 
57.28 
5.19 
20.55 
1.75 
11.90 
30.53 
C~se 
fixed 
2595 
596 
834 
927 
130 
117 
267 
585 
518 
T 
tnlS. 
2.47 
8.40 
29.36 
58.25 
6.24 
21.41 
2.84 
12.97 
31.63 
C'3HH 
fixed 
790§ 
1460 
1776 
1850 
350 
369 
630 
1560 
1640 
T 
mln. 
2.22 
8.18 
28.81 
57.70 
5.59 
15.81 
2.19 
12.46 
31.07 
Dism- 
eter of 
skin re- 
sponse 
ram.* 
11.8 
12.2 
14.6 
15.0 
9.9 
9.0 
10.5 
13.8 
14.7 
Schultz- 
T  Dale re- 
sponse 
rain.  ram. 
2.47 
8.40 
29.36 
58.25  86 • 
6.24  5 b 
21.41  3  b  0 • 
2.84  9  b 
12.97  48  b 
31.63  44  b 
* Standard error of the difference ffi 1.8. Flask B--25.0 ml. rat serum plus 0.25 ml. of 1.0 
EDTA (pH =  8.0) plus 5 ml. of PIA as above. After sample was taken at 20.55 minutes, 
flask received 0.21 ml. of 1.0 x~ Mg++ and 0.2 ml. of 0.01 M Ca  ++. The next 3 samples were 
then taken as indicated. 
930 C~  initially available in 26.5 ml. of reaction mixture in flask A which contained 
22 ml. of rat serum and 4.5 ml. of PIA (120 #g. anti-Ea N per ml.). All values corrected to 
1000. 
§ 2370 C'3I-I~0  available. 
sible multiplicity of the reaction involving C'8. The temperature requirement 
for anaphylatoxin production through the utilization of  C' is in accord with 
the observation that of all the known C ~ components, C'3 exhibits the most 
marked  temperature dependency (18).  It is  also  noteworthy that  the  more 
rapid genesis of anaphylatoxin at 37°C. has been reported by many other in- 
vestigators, an observation that applies as well to the release of histamine and 
5-hydroxytryptamine  from a variety of tissue preparations by antigen-antibody 
interaction and other means (5, 37--45). 
The  failure of  hydrazine-treated rat  serum  to  yield active  anaphylatoxin A.  O.  OSLER,  H.  O.  RANDALL,  B.  M.  HILL,  AND  Z.  OVARY  323 
preparations  was  interpreted on the basis  of  C', inactivation by the  amine. 
An attempt was made to confirm this irderence through the use of a chelating 
agent which would deprive the reaction system of the divalent cations required 
for the interaction of C'1 and C'2, as well as C',. This experiment is summarized 
in Table IV and Figs. 5 to 7. In this experiment, flask A contained rat serum 
and  PIA.  The  contents  of  flask  B  were  identical  except for  the  addition 
I000 - 
900- 
800- 
7OO- 
GOO- 
w  x 
u.  500- 
b  400- 
200- 
IO0- 
~a  t C' by P:formed Immune 
/  Aggr~ates  of Ra-a-Eat-Ea  at Equivalence 
/~  Zone Ratl~. 20.ug.  AbN/ml.Reaotion  Mixture 
 OTA  + 
(001 M) 
i  I  i  i  i  i  1  i  i  i  i  | 
5  I0  15  20  25  30  35  40  45  50  55  60 
TIME IN MINUTES 
]~0.  5. 
of Naj-IEDTA in a  final concentration of 0.01  •.  Both flasks were sampled 
intermittently during  a  1 hour interval.  When  the  reaction in flask  B  had 
proceeded for  about  20  minutes,  Ca  -~  and  Mg  ++  were  added  in  amounts 
su/ficient to neutralize the effects of  the  EDTA and  in  addition,  provide a 
slight  excess.  As  may be  noted,  the  incorporation of these  metal  ions  was 
rapidly followed by a  marked loss  of hemolytic activity, inactivation of C'3 
and a  simultaneous emergence of anaphylatoxic activity. The data in Fig.  7 
illustrate the results obtained with one of the segments of guinea pig ileum used 
for the  study  of smooth  muscle  contraction in  this  experiment.  Since  Nas 
HEDTA in concentrations ranging from 0.002 to 0.016 ~  had no suppressive o~  o 
P 
CD 
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action on the contraction  of guinea pig ileum by preformed anaphylatoxin, 
it is dear that the processes involving the formation of this substance and the 
fixation of C' require the presence of divalent cations. 
Similar  results with respect to the suppressive effect of Na3 HEDTA on C' 
utilization and skin blueing potency have been observed in other experiments 
in which anaphylatoxin was generated in guinea pig and in rat serum by the 
addition of agar. As was also the case with PIA, anaphylatoxin production in 
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FIG.  6. 
rat and guinea pig serum by agar was restored upon the addition of divalent 
cations. 
The significance  of  the  preceding  experiment may be ascribed  to  the demon- 
stration that interference with the utilization of C' by an immune aggregate 
prior  to the uptake of C't and  C'4 simultaneously suppressed the biological 
activities associated with anaphylatoxin. The soundness of this interpretation 
with respect to  C' participation  was tested in a  number of experiments de- 
signed  to inhibit  C t utilization  at a  subsequent step, namely, the utilization 
of C'a. It had been observed in this laboratory that the glucoside,  phlorizin, 
effectively prevents the participation  of C'~ in immune hemolysis (46).  Anti- 
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phagocytic properties of phlorizin have  also been reported (47  and 47a).  Ac- 
cordingly, the  effect of this anticomplementary agent  on anaphylatoxin pro- 
duction was investigated with results such as those summarized in Table V and 
and Figs. 8 to 10. A  time course study over a 90 minute period showed that the 
loss  in  over-all  hemolytic  activity  proceeded  with  equal  rapidity  in  both 
TABLE V 
Fixation of Complement and Formation of Anaphylatoxin by Preformed Immune Aggregates: 
Inhibition by Pldorizin 
mln. 
1.08 
3.21 
5.54 
9.97 
17.96 
27.90 
54.82 
90.72 
1.17 
3.30 
6.32 
10.20 
19.45 
30.01 
59.64 
92.59 
C'H~ fixed* 
669 
1043 
1295 
1417 
1488 
1530 
1635 
1643 
774 
1194 
1394 
1488 
1538 
1614 
1627 
1639 
C'3Hse fix-4÷  T  Diameterlof  T  ~÷  skin response 
Flask A--in absence of phlorizin 
3.58 
5.99 
10.42 
18.96 
28.50 
55.21 
90.79 
1.35  1181 
2542 
3316 
3639 
3804 
3977 
4206 
4270 
1.35  11.2 
3.58  12.9 
5.99  14.4 
10.42  13.8 
18.96  12.9 
28.50  14.1 
55.21  14.5 
90.79  13.8 
Flask B--in presence of phlorizin (0.005 u)¶ 
1.44 
3.64 
6.67 
10.64 
19.91 
30.40 
60.05 
93.18 
694 
1181 
1942 
2264 
2437 
2575 
2838 
2876 
1.44 
3.64 
6.67 
10.64 
19.91 
30.40 
60.05 
93.18 
9.5 
10.7 
10.8 
12.1 
12.3 
12.4 
12.2 
12.2 
Schultz- 
T  Dale re- 
SpOll~ 
m4~.  ram. 
1.08  3" 
2.85  56 • 
5.06  73" 
9.57  83" 
17.42 
27.40 
54.51  96  b 
90.23  158  b 
0.88  0 e 
2.56  4 ° 
6.05  40 
9.70  10° 
18.86 
29.38  13  b 
59.18  36  b 
91.99  54  b 
* Total C'I-~0 available; 1740 in 35  ml. 
$ Total  C'3Hi0  available; 5080 in  35  ml. 
§ Standard error of the difference =  1.5. 
¶ Dissolved directly in reaction mixture, i b o  each letter refers to the 5  specimens in- 
cluded in one of the three smooth muscle analyses. Each number represents sum of contrac- 
tions of 5 trials. 
flasks A  and B, which differed one from the other only in that the latter con- 
tained phlorizin at a  final concentration of 0.005  ~  (see Fig. 8).  Cessation of 
the experiment at this juncture would have failed to demonstrate the simul- 
taneous diminution in the inactivation of C'3 (Fig. 9), the lessened enhancement 
of capillary permeability (Fig. 9),  and the marked suppression of the smooth 
muscle response (Fig. 10). 
These data provide striking confirmation to the notion gained from hemolytic 
studies  (46),  that the inhibitory activity of phlorizin is directed at a  stage in 1600- 
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FIG. 9. /k  O-Fixation of C'3Hs0 from rat serum by preformed  immune aggregates of Ea 
+  rabbit---anti-Ea (20 #g antibody hi per ml.); inhibition by phlorixin. A  Q-Skin Respon- 
ses induced by the C' fixation mixtures. 
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the lyric process subsequent to the utilization of C'1, C'4, and C'~. The fixation 
of these components expl~in~ the results depicted in Fig. 8 in showing that the 
loss  of hemolytic  activity occurs equally well  in  both flasks  and  is  not in- 
fluenced by the presence of phlorizin.  The inhibitory properties of this reagent 
on anaphylatoxin formation  and on C'3 inactivation  by PIA have also been 
duplicated with agar anaphylatoxin and in guinea pig serum as well. 
~ 
160- 
~ 
140- 
--  17-0- 
E 
;  100  ~ 
~  80- 
O 
60- 
O 
o 
|  I  I  I  I  '  "  !  ....  I  "  ="  I  '  I 
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FIo. tO. Schultz-Dale reactions, Rat serum treated with preformed aggregates of rabbit 
anti-Ea -b Es (20 ~g antibody N per ml.); inhibition by phlorizin. 
Further  evidence as to the mechanism of anaphylatoxin formation and its 
inhibition by phlorizin  are provided by the data in Table VI which describes 
one of several experiments with protein and polysaccharide immune systems. 
It is  apparent  that  phlorizin  exercises  its primary  action in suppressing  the 
formation of anaphylatoxin.  This is indicated by a comparison of the results 
obtained in tubes 5 and 3 with those of tubes 5 and 4. The presence of phlorizin 
at the inception of the immune reaction restrains the production of anaphyla- 
toxin presumably through  a bloc at the C'~ stage (Table V, Figs.  9 and  10). 
Once formed, the effect of anaphylatoxin in terms of smooth muscle contrac- 
tion  is  almost fully expressed  even when phlorizin  is  added to the  Schultz- 
Dale bath. It should be pointed out that at concentrations considerably higher A. 0. OSLER~ H. O. RANDALL~ B. M. HILL~ AND  Z. OVARY  329 
than those used for the conditions of testing in tubes 3 and 4, phlorizin  will 
partially inhibit the smooth muscle contraction owing to added histamine. 
The data in Table VI also indicate the broader range of quantitation provided 
by the Schultz-Dale experiments as contrasted to the capillary permeability 
measurements. In the latter case, it is perhaps noteworthy that phlorizin also 
exerts a suppressive action on the skin blueing of the antibody controls (tubes 
1 and  2), in view of the anticomplementary  and skin-blueing  properties as- 
sociated with gamma globulin (48 and 49). 
TABLE VI 
Comparison of the Inhibitory E~ect of Pldorizin on Anaphytaloxin Formation and on Smooth 
Musde Contraction 
Tube  Reaction mixture*  Diluted in  Schultz-Dale  Diameter  of  response  skin response 
Ra-anti-Ea 
Ra-anti-Ea 
Ra-anti-Ea reacted with Ea in 
plflofizin 
Ra-anti-~.a reacted with Ea in 
saline 
Ra-anti-Ea reacted with Ea in 
saline 
Pblor~n$ 
Saline 
Saline 
Phlorizin 
Saline 
W° 
s~ 
17 
14 
45 
49 
7.sil 
10.5 
10.9 
15.1 
17.0 
* These reactions were carried  out with 50 pg. anti-Ea N,  /~g. Ea N, and 2.5 ml. of 
fresh rat serum at 37°C. for 90 minutes.  Tubes 1 and 2 lacked antigen.  Tube 3 contained 
ptdorizin at a final concentration  of 0.006 ~r. The reaction mixtures were then diluted in iso- 
tonic NaCI (tubes 2, 3, and 5) or in saline containing phlorizin to yield a final concentration 
of 0.0004 M for the guinea pig skin tests. 
Final  concentration  of phlorizin  in bath fluid =  0.00003 
§ Standard error of the difference =  2.8. 
]~ Standard error of the difference ffi 1.4. 
Much evidence has been accumulated  in recent years relating the property 
of various dextran preparations to the release of histamine and to the induction 
of  anaphylactoid  reactions  in  different  hosts  and  under  various  experi- 
mental conditions (50--60). It was therefore of interest  to investigate the anti- 
complementary activities  of these  glycosides and the results  of these  experi- 
ments are presented  in Table VII. The findings of Taylor and Walton have 
been confirmed with respect  to the ability of dextrans to inhibit complement 
activity  (61).  Further,  these  data  may be  considered  to  provide  additional 
evidence for the concept ascribing the intervention of C' and C's in the chain 
of reactions leading  to capillary permeability  enhancement,  and induction of 
smooth  muscle  contraction.  Particular  note  has  been  taken  of  the  bimodal 
variation  in  the  anticomplementary  and  associated  activities  with  average 
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These findings have been duplicated in repeated experiments with  different 
shipments of the same dextran preparations.  They serve to emphasize that the 
average molecular weight, as deduced by light scattering measurements,  is not 
the sole  determinant  of  the  anticomptementary  property  attributed  to these 
dextrans. When the several preparations were dissolved in veronal  buffer at  a 
concentration  of 15  mg./ml.,  it  was noted that dextrans  2,  6,  and  8  yielded 
TABLE VII 
Fixation of Complement and  Formation of Anaphylatoxin: the Interaction of Dextran with 
Fresh Rat Serum* 
Commercial 
Solvents Cor- 
poration No. 
Dextran preparatlon~ 
Average  molec-  O.D.§ 
ular weight 
None 
33,300  0.132 
56,400  0.011 
91,700  0.015 
123,900  0.012 
194,900  0.120 
255,000  0.013 
412,000  0.119 
C'H,e fixed[[ ]C'3Hi_~s 
0 
127  5 
37 
48 
64  1 
148  5 
61  1 
175  7 
..  Diameter of 
0 
.~0 
0 
0 
)2 
56 
)1 
.~0 
Schultz-Dale 
respomeII 
8.0 
15.2  40  b 
8.1  2 b 
9.6  64  (1  b) 
13.s  9. (4  b) 
16.7  31 s (52  b) 
13.2  6 ~ 
17.5  35~ 
* Each reaction mixture contained 5.0 mL of fresh rat serum (absorbed twice with sheep 
red cells) and 100 mg. of the designated dextran preparation.  The mixtures were incubated 
for 37°C. for 60 minutes, centrifuged at 12,000 g for 20 minutes, and the supemates analyzed. 
The authors express their gratitude to the Commercial Solvents Corporation for supply- 
tug two series of these dextran preparations,  described as predominantly  1 to 6 linkages with 
3 to 4 per cent in non-1  to  6  linkages. 
§ Optical density of solution containing 15 rag. per ml. of veronal buffer at 400 m/~ in a 
Beckman  DU spectrophotometer. 
[[ 196 C'Hs0 available for the reaction. 
¶ 900 Ct3Hs0 available  for the reaction. 
** Standard error of the difference is 1.3. 
~  The superscripts  s and  b refer to each of two different assays. 
opalescent  solutions,  an observation verified  by the  optical density measure- 
ments  given  in  Table  VII.  It  is  perhaps  of more  than  casual  interest  that 
Kabat and Bezer studied the same dextran preparations as antigens in human 
beings and reported  that a  molecular weight of less than  51,000 was not as- 
sociated with  antibody production  (62).  If the destruction  of C' components 
and production of anaphylatoxin by these dextrans is considered in the light 
of a  specific  immune  reaction,  it  would  appear  that  the  tendency  of  these 
dextrans to aggregate requires further study as one of the variables in addition 
to the molecular weight characteristics. Thus, when aggregation of the dextrans A.  G.  OSLER,  R. G.  RANDALL,  B.  M.  HILL,  AND  Z.  OVARY  331 
was minimized by careful solution in  buffer for a  1 or 2  day period,  before 
addition  to the rat serum,  the extent of C' destruction was greatly reduced, 
although the relationships between  the preparations were not  disturbed.  The 
presence  of  these  complicating factors  increases  the  problem  of  elucidating 
the mechanism underlying the action of dextran (cj*. reference 50). With respect 
to the question under study, it is clearly apparent that the C'-fixing potencies 
of the members of this series of dextrans correlate very well with the destruc- 
tion of C'8 and anaphylatoxin formation. 
DISCUSSION 
The  major objective of this  investigation  is  the  design  of  critical  experi- 
ments bearing on the participation of C' in the production of anaphylatoxin. 
In one sense,  it  may be considered  as a  continuation  of earlier  experiments 
directed towards an evaluation of the role of C' in passive cutaneous anaphy- 
laxis (1). 
In the latter situation, a  series of correlated experiments demonstrated that the 
cutaneous allergic  response could  be controlled  in a manner entirely comparable to 
the  in ~/tro  C  ~ fixation  reaction.  In  the  anaphylatoxin studies,  one  allergic  phe- 
nomenon has been transposed to in ~itro conditions  utilizing  a cell-free, fluid reaction 
system in which  the relationship of anaphylatoxin to C  ~ fixation has been brought 
into sharper definition.  As noted previously (2,  3),  the major difficulty  pervading 
both experimental approaches relates to the methods at hand for the identification 
of that complex of serum constituents whose sequential action has been grouped in 
the single term, C  ~. 
Through  the application of the operational criteria which  characterize the 
properties  of  C'  as  gleaned  from studies  of immune hemolysis  (18)  and  C' 
fixation in highly dilute systems (27), the evidence now available perhaps pro- 
vides a  more substantial  basis for accepting the  concept that  anaphylatoxin 
formation may be regarded  as one of the  consequences  of C ~ fixation in re- 
actions involving the established sequence of all of the known components. 
The  experimental findings  which  support  this  conclusion  may be recapitulated 
in terms of the known properties of C  t. Thus, the thermal inactivation of hemolytic 
activity  through destruction of the heat-labile  components,  C'I and C',  (56°C.-30 
minutes)  renders  serum unsuitable  for  anaphylatoxin production  by immune  ag- 
gregates, agar, trypanosomes, or other means (6, 37, 39, 43, and others). An attempt 
to distinguish between serum and tissue C t on the basis of thermal inactivation con- 
ditions has led some investigators to conclude  that C  ~  plays no role in the release of 
histamine by antigen from sensitized  and minced guinea pig lung  tissue  (40,  41). 
This conclusion  may be questioned  on two counts.  The degree of inactivation  of 
thermolabile components is probably a function of initial concentrations, and since 
tissue C  ~ has neither been detected nor estimated, the deduction as to its thermola- 
bility  relative  to  serum  C ~ would  appear  premature  and  possibly  unwarranted. 332  MIECIIANISM OF HYPERSENSITIVITY pHENOMENA.  HI 
Further, exposure  of  the  total reaction  system involving  antigen, antibody, and 
histamine-containing  cells to a  temperature of 45°C. for 20 minutes may produce 
an irreversible change in the tissue, an effect very likely independent of C' stability, 
but incapable of resolution in so complex a reaction mixture. 
The fixation of C' as a secondary manifestation of aggregate formation has recently 
been discussed with respect to hemolytic studies (27). The unexpected findings with 
dextran (Table VII) are provocative  in this connection. In addition, the findings in 
Table II  (Figs.  1 to 4) show that anaphylatoxin production is likewise influenced 
by the ratio of antigen to antibody and structure of the immune aggregate. This is 
regarded  as important contributory evidence to the concept of C' participation in 
allergic phenomena and has recently received independent confirmation in the studies 
of Ishizaka, Ishizaka, and Campbell  (63)  7, These investigators  report that the ca- 
pacity of soluble BSA-anti-BSA  complexes to enhance capillary permeability,  and 
to fax C', was lost when the composition of these complexes attained the limiting 
molar ratio, Ag~b, in marked BSA excess. Of similar import in the present connection 
is their finding that simple hapten-antibody complexes lack both skin activity and 
the capacity to fix C'. 
Throughout the conduct of this investigation, it became increasingly ap- 
parent that the biological activities associated with anaphylatoxin were better 
correlated  with  C'a utilization than with  the  over-all  loss  in hemolytic C' 
potency which may occur following the fixation of C'1, C% and C'2, singly or 
in combination. The failure to follow the fate of C'8 may account in part for 
the inability of numerous investigators over the past few decades to correlate 
C' activity with disease processes  (64, 65).  Data such as those obtained with 
tubes 7, 9,  10, and 12 of Table HI are pertinent. Thus, in tubes 7, 9, and 10, 
hemolytic activity was inactivated either through storage of the fresh serum, 
or treatment with immune aggregates at 0°C.  without substantial losses  of 
C's  or  genesis  of  anaphylatoxin. The  further  addition  of  antigen-antibody 
aggregates and incubation at 37°C. resulted in marked C's inactivation, capil- 
lary permeability increase,  and  smooth musde contraction. With  the  lyric 
activity alone as a  guide, tubes 10,  12, and 13 would have appeared almost 
indistinguishable (aft  also reference 27). 
In an analogous fashion, the results obtained in tubes 14 and 15 help darify 
the conflicting reports on the ability of heparin to inhibit anaphylatoxin for- 
mation (of.  references 4, 38, 39, and others). Partial inhibition is noted in tube 
15 as compared with tube 13 lacking heparin. However, slight alterations in 
heparin concentration might alter the result in either direction depending on 
the amount and concentration of  C'3  available for the reaction,  method of 
measuring anaphylatoxin activity, etc. 
Similar considerations apply to the experiments with EDTA and phlorizin 
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as  simultaneous  inhibitors  of  C'  utilization  and  anaphylatoxin  formation 
(Tables IV and V, Figs. 4 to 9). These data extend the observations in Table 
III in the demonstration that the interposition of a bloc at any stage in the 
C' fixation sequence, e.g., before or after the participation of Crl, C'4, and Cr~ 
(the former, v/a metal chelation, the latter, with phlorizin) concurrently sup- 
presses the biological manifestations attributed to anaphylatoxin. 
The requirement for divalent cations in the interaction of Crl, C~4, and C'~ 
with immune complexes (18) is paralleled by the numerous reports showing a 
similar requirement for the release of histamine from human blood (66,  67), 
from minced guinea pig lung tissues  (45),  from platelets  (28,  39)  and  also 
for anaphylatoxin production (6). 
These findings emphasize the necessity of  considering C' in terms of the 
entire complex of components and  their sequence of action. These comments 
are not directed towards  assigning greater importance to one or the other of 
the C' components in the total process.  On the contrary,  it appears  thus far 
that the individual steps in the multiple processes which result in the evocation 
of anaphylatoxin responses  are  entirely analogous to  the  reaction  sequence 
described by Mayer and his associates  for immune hemolysis (18).  The con- 
clusion relative to the participation of C ~ in these allergic manifestations does 
not exclude the possibility that other as yet unknown factors,  in addition to 
antigen, antibody, and  C  r, may be operative in these experiments.  Further 
studies on the mechanism of  anaphylatoxin formation may serve to disclose 
their presence. 
The  present  set  of  experiments also  demonstrates that  the interaction of 
immune complexes in fresh serum stimulates the production of anaphylatoxin, 
thus clarifying one of the possible mechanisms of action of soluble complexes 
(63, 68, 69). The action of these aggregates has received much study recently 
in the thought that they may play a significant role in anaphylatic phenomena. 
Soluble complexes may possess inherent attributes of importance other than 
the ability to fix C', such as their capacity to fix to tissue sites. In any event, 
immune complexes fix C'  and produce anaphylatoxin. These properties  are 
dependent on the antigen: antibody ratios of the complexes and events of this 
nature occurring in the bloodstream may also contribute to the total tissue 
injury associated with anaphylactic reactions. 
It may be appropriate  to note that the significance attached to the earlier studies 
of  anaphylatoxin by  Friedberger,  Bordet,  and  Novy  and  DeK_ruif was  sharply 
diminished  with the advent of Dale's studies  with isolated  smooth muscle. This 
diminution in interest was occasioned in large measure by the results  of Dale's in- 
vestigations which placed greater  emphasis on the events at the cellular rather than 
humoral level (70, see also references 4 to 6). Moreover, the demonstration by Bordet 
that agar can activate anaphylatoxin, initiated an as yet unfinished series of publi- 
cations  pertaining to the "non-specific"  activators which include dextrans,  inulin, 334  MECHANISM  OF  HYPERSENSITIVITY  PHENOMENA.  III 
liquoid,  starch,  zymosan, etc. The earlier experiments, many of which  have been 
summarized in references  71 and 2 led to the use of the term "anaphylactoid"  with 
the implication that the mechanism of anaphylatoxin release under these conditions 
differs from that induced by antigen-antibody interaction. While  this interpretation 
may prove correct, studies in this laboratory and by Manski  (72, 73)  have shown 
that dextran, inulin,  agar, zymosan, and llquoid  activate anaphylatoxin and destroy 
Ct, in the process (3). Further, as shown in this study, the capillary permeability en- 
hancement and smooth muscle contraction mediated by agar have been effectively 
curtailed  by EDTA and  phlorizin.  These observations as well  as  the  inability of 
agar to produce anaphylatoxin at low temperatures, in ammonia-treated serum, or 
in  heated  serum  provide  reasonable  ground  for  speculating  that  the  so  c~lled 
"anaphylactoid"  phenomena are closely similar to the more familiar immune processes 
(el. also references  5, 2, 3). The observations with respect to C  t utilization and ana- 
phylatoxin production by zymosan are also pertinent in this connection  (2, 74). 
As  noted  above,  the  role  that  may be  assigned  to  anaphylatoxin  in  the 
totality  of  events  associated  with  allergic  reactions  of  the  immediate  type 
remains  to  be  evaluated.  Current  appraisal  is  di~cult  because  of  the  con- 
tradictory conclusions drawn by different investigators. 
Halpern and his colleagues have shown that sublethal injections of anaphylatoxin 
protect  guinea  pigs  against  an  otherwise  fatal,  passively  induced,  anaphylactic 
shock (75). Greisman has arrived at a diametrically opposed conclusion  on the basis 
of studies with the Schultz-Dale bath (76). The latter are subject to considerable  un- 
certainty because of technical problems with respect to the efficacy of desensitizing 
guinea pig ileum and the restoration of reactivity solely as a function of time. Further, 
Mota has claimed that anaphylatoxin does not liberate histamine from mast cells 
of rats (77), an opinion that is not shared by Keller (51) for rat mast cells, nor by 
Gem~.hlich and his colleagues (78) for guinea pig cells, or by Rocha e Silva (reviewed 
in reference 6). 
The studies reported by Giertz et al. indicate that anaphylatoxin may only mediate 
the  cytotoxic type of reaction  (79).  This conclusion  is based on experiments with 
hepaHn which has been found in this laboratory to inactivate Cr3 but only to a limited 
extent,  depending  on  factors such  as  discussed  previously. The failure to  inhibit 
anaphylaxis  may  therefore  not  be  admissible  as  conclusive  evidence.  A  possible 
relationship of anaphylatoxin to hemolytic reactions in human beings  may be in- 
ferred from the studies of Jandl and Tomlinson (80). 
The advantages which accrue from the utilization of a  cell-free system in- 
volve a greater flexibility in experimental design and thereby facilitate studies 
directed towards the elucidation of the mechanism underlying the appearance 
and  action of anaphylatoxin.  Further,  studies  directed  towards a  characteri- 
zation of this substance(s) from a  fluid,  cell-free medium can be approached 
more  readily.  The  fact  that  anaphylatoxin  reproduces  the  tissue  responses 
deemed  characteristic  and  fundamental  to  in  ~ivo anaphylactic  reactions 
heightens interest in its continued study. It would appear at this stage of the 
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cation of C' components (81) and in the development of chemical methods for 
identifying and  estimating anaphylatoxin activity. The  application  of  such 
procedures  in addition to  those used in this  study might prove of value in 
defining the significance of anaphylatoxin in the mediation of allergic reactions 
of the immediate type, and in the soundness of the rationale which aims at 
circumventing the associated tissue damage through an interference with the 
fixation of C  ~. 
SUMMARY 
The interaction of fresh rat and guinea pig serum with washed preformed 
immune aggregates has  been  studied with  respect  to  the  loss  in hemolytic 
potency of the serum, diminution of the Cts activity, and appearance of ana- 
phylatoxin. 
It has been found that the formation of anaphylatoxin, as judged by its 
effect on capillary permeability and smooth muscle contraction, is coincident 
with or subsequent to the fixation of all the known C  ~ components. 
Less anaphylatoxin is formed by aggregates formed with excess antigen than 
those in equivalence ratio combination. 
C  ~ fixation, as well as anaphylatoxin production, may be inhibited by chela- 
tion of the divalent cations, presumably by interfering with the fixation of 
CI1, C% and C'~. 
Phlorizin suppresses the utilization of C'3 in immune hemolysis, C  ~ fixation 
by  antigen-antibody aggregates,  and  the  production of anaphylatoxin. The 
biological activities associated with the fixation of C  ~ are not manifest unless 
C~8 participates  in this process  at 37°C.  It is concluded that the formation 
of anaphylatoxin may be regarded as a product of C' fixation. 
The  authors wish to  express their appreciation for the  technical assistance of Mr. 
Clarence R. Stewart, Jr. 
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